Get started
Author

Amal T. Qattan

Observed names: A. Qattan, Amal Qattan, Amal Qattant, Qattan, Amal
Observed institutions: Alfaisal University, George Washington University, Georgetown University Medical Center, King Faisal Specialist Hospital & Research Centre, The Royal Free Hospital, University College London
ORCID: 0000-0001-7362-789X
Observed ORCID: 0000-0001-7362-789X
OpenAlex ID: A5018442918
The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors
2006 · Hazem Ghebeh, Shamayel Mohammed, et al. · Neoplasia · 628
PDF
PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
2017 · Sheema Almozyan, Dilek Colak, et al. · International Journal of Cancer · 250
PDF
Robust expression of tumor suppressor miRNA’s let-7 and miR-195 detected in plasma of Saudi female breast cancer patients
2017 · Amal Qattan, Haya Intabli, et al. · BMC Cancer · 70
PDF
Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
2020 · Amal Qattan · International Journal of Molecular Sciences · 59
PDF
Spatial Distribution of Cellular Function: The Partitioning of Proteins between Mitochondria and the Nucleus in MCF7 Breast Cancer Cells
2012 · Amal T. Qattan, Marko Radulovic, et al. · Journal of Proteome Research · 43
Quantitative Organelle Proteomics of MCF-7 Breast Cancer Cells Reveals Multiple Subcellular Locations for Proteins in Cellular Functional Processes
2009 · Amal T. Qattan, Claire Mulvey, et al. · Journal of Proteome Research · 40
Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer
2020 · Ashraf N. Abdalla, Amal Qattan, et al. · Molecules · 34
PDF
Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
2021 · Amal Qattan, Taher Al-Tweigeri, et al. · Genes · 33
PDF
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
2021 · Ashraf N. Abdalla, Waleed H. Malki, et al. · Molecules · 28
PDF
Gene expression profiling in women with breast cancer in a Saudi population
2008 · Suad M. Bin-Amer, Zakia Maqbool, et al. · Saudi Medical Journal · 22
Systematic Nucleo-Cytoplasmic Trafficking of Proteins Following Exposure of MCF7 Breast Cancer Cells to Estradiol
2014 · Gabriella Pinto, Abdulrab Ahmed M. Alhaiek, et al. · Journal of Proteome Research · 17
Glucocorticoid induced loss of oestrogen receptor alpha gene methylation and restoration of sensitivity to fulvestrant in triple negative breast cancer
2022 · Haya Intabli, Julia M. Gee, et al. · Gene · 14
PDF
Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis
2025 · Minjing Zou, Amal Qattan, et al. · Frontiers in Endocrinology · 11
Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer
2022 · Amal Qattan, Taher Al-Tweigeri, et al. · Biomedicines · 11
PDF
Identification of novel prognostic biomarkers for thyroid cancer by integrated transcriptome analysis of metastasis-associated genes
2025 · Bushra Alnwisser, Salman Alshehri, et al. · Frontiers in Oncology · 8
PDF
Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC)
2024 · Amal Qattan · International Journal of Molecular Sciences · 8
Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC)
2024 · Amal Qattan, Taher Al-Tweigeri, et al. · Cancers · 7
Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression
2021 · Rayanah Barnawi, Samiyah Al-Khaldi, et al. · Pharmaceuticals · 6
PDF
β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells
2023 · Minjing Zou, Suhad Al-Yahya, et al. · Frontiers in Immunology · 5
PDF
Subtype-Specific m6A circRNA Methylation Patterns Identify Epigenetic Biomarker Candidates of Potential Diagnostic and Prognostic Significance in Breast Cancer
2026 · Amal Qattan, Wafa Alkhayal, et al. · International Journal of Molecular Sciences · 4
The effect of cortisol on methylation patterns in breast cancer cell lines
2019 · H. Intabli, M.S. Flint, et al. · Annals of Oncology · 3
PDF
Metabolic Reprogramming of Triple-Negative Breast Cancer: The Role of miRNAs
2017 · Amal Qattan · microRNA Diagnostics and Therapeutics · 3
State-Aware RNA Biomarkers in Triple-Negative Breast Cancer (TNBC): Integrating Tumor Plasticity, Spatial Architecture, and Temporal Monitoring
2026 · Amal Qattan · International Journal of Molecular Sciences · 2
Duplicitous Dispositions of Micro-RNAs (miRs) in Breast Cancer
2019 · Amal Qattan · IntechOpen eBooks · 1
Gene Silencing Agents in Breast Cancer
2019 · Amal Qattan · IntechOpen eBooks · 1
PDF
Works count: 35
Citation count: 1,309
H-index: 12
I10-index: 14
Year
Topic
Type